Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04568616 |
| Title | Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) (NAOMI) |
| Acronym | NAOMI |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Dartmouth-Hitchcock Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dartmouth Hitchcock Medical Center | RECRUITING | Lebanon | New Hampshire | 03756 | United States | Details |
| Dartmouth-Hitchcock Medical Center | RECRUITING | Lebanon | New Hampshire | 03756 | United States | Details |